Smartleaf Asset Management’s Avidity Biosciences RNAM Stock Holding History

Smartleaf Asset Management’s Portfolio RNAM Stock Details RNAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-490	Closed	-$35.4K	–	3624
2025 Q4	$35.4K	Buy	490 +397	+427%	+$25.6K	﹤0.01%	1718
2025 Q3	$3.96K	Buy	93 +54	+138%	+$2.18K	﹤0.01%	2449
2025 Q2	$1.13K	Sell	39 -51	-57%	-$1.52K	﹤0.01%	2458
2025 Q1	$2.84K	Buy	90 +7	+8%	+$218	﹤0.01%	2380
2024 Q4	$2.42K	Hold	83	–	–	﹤0.01%	2482
2024 Q3	$3.51K	Sell	83 -7	-8%	-$304	﹤0.01%	2269
2024 Q2	$3.65K	Buy	+90	New	+$2.58K	﹤0.01%	1959

Other funds holding RNAM

Corsicana & Co Corsicana, Texas $158M AUM

Smartleaf Asset Management's RNAM Position: Q1 2026 in Review

Smartleaf Asset Management sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 490 shares — an estimated $35.4K sold.

Smartleaf Asset Management first reported a position in RNAM in Q2 2024 and held it in 7 quarters. The position peaked at $35.4K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

Smartleaf Asset Management reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
Smartleaf Asset Management sold 490 Avidity Biosciences shares in Q1 2026, an estimated $35.4K.
Smartleaf Asset Management first reported a position in Avidity Biosciences in Q2 2024 and held it in 7 quarters.
Smartleaf Asset Management's Avidity Biosciences position peaked at $35.4K in Q4 2025.
1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.